FDA Inspection 750998 — Geisinger Medical Center Blood Bank
The FDA completed an inspection of Geisinger Medical Center Blood Bank on October 25, 2011 in Danville, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 25, 2011
- Fiscal Year
- 2012
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Danville, PA (United States)